Mometasona Furoato Stada (Mometasone Furoate Anhydrous)

Mometasone furoate, the active ingredient in Mometasona Furoato Stada, is a corticosteroid presented as a nasal spray for intranasal use. It reduces nasal inflammation associated with allergic rhinitis and related conditions. The product is marketed in the European Union and follows GMP standards for quality and safety.

GNH USA supplies Mometasona Furoato Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate nasal spray works on inflammatory pathways of the nasal mucosa to relieve symptoms of several upper‑respiratory conditions. - Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea caused by allergens. - Nasal polyps: helps shrink polyps and improves airflow after surgical removal. - Non‑allergic rhinitis: alleviates inflammation‑related nasal symptoms in patients without an allergic trigger.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleeds) - Sore throat - Cough - Altered taste or smell

Serious or Rare Side Effects: - Nasal septal perforation - Severe or persistent epistaxis - Vision changes (e.g., cataracts, glaucoma) - Adrenal suppression with prolonged high‑dose use - Hypersensitivity reactions such as rash or anaphylaxis - Secondary infections of the nasal mucosa

Before using Mometasone furoate nasal spray, consider the following safety measures. - Pregnancy: consult a healthcare provider before initiating therapy. - Breastfeeding: discuss potential risks and benefits with a physician. - Active infections: evaluate and treat local or systemic infections prior to use. - Long‑term therapy: monitor for adrenal insufficiency and intra‑ocular pressure. - Nasal surgery or trauma: discontinue the spray before and after procedures as advised. - Known hypersensitivity: avoid if allergic to mometasone or other corticosteroids. - Store at room temperature: keep in the original container, protect from moisture and light.

Mometasone furoate nasal spray can interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local exposure and risk of side effects.

Moderate Interactions (Monitor Closely): - Antifungal agents metabolized by CYP3A4 (e.g., fluconazole): monitor for enhanced effects. - Ritonavir or other protease inhibitors: may modestly increase mometasone levels. - Antihistamines: additive sedation is uncommon but monitor patient comfort.